May 3 (Reuters) - Next Science Ltd (NXS) :
- IMMEDIATE PRIORITIES FOR FY24 TO DELIVER SIGNIFICANT TOPLINE GROWTH ACROSS 3 KEY AREAS OF BUSINESS.
- SEES FY24 REVENUE OF US$36M-$40M
- SEES EBITDA AND CASHFLOW POSITIVE POSITION IN SECOND HALF OF THIS YEAR
(([email protected];))
News: NXS Next Science Sees FY24 To Deliver Significant Topline Growth Across 3 Key Areas Of...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $56.97M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 19.0¢ | $1.947K | 9.789K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8695 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 45449 | 1 |
View Market Depth
| Last trade - 11.49am 11/10/2024 (20 minute delay) ? |
| NXS (ASX) Chart |